Archivio > News 2004

Page last update:

• Lancet 1 gennaio
  • Evidence-based practice and the individual
  • Treating Individuals 1 :External validity of randomised controlled trials: "To whom do the results of this trial apply?"

• BMJ 1 gennaio
  • The GMC: expediency before principle
  • Direct to consumer advertising
  • ABC of preterm birth: Evidence based care
  • Switching prescription drugs to over the counter

• N Engl J Med, 30 dicembre
  • Potential Pitfalls of Disease-Specific Guidelines for Patients with Multiple Conditions

• BMJ, 18 dicembre
  • Lifting the fog of uncertainty from the practice of medicine
  • The Decameron of poor research
  • A field guide to experts
  • Easy ways to resist change in medicine
  • Killing me softly: myth in pharmaceutical advertising

• JAMA, 15 dicembre
  • The Rational Clinical Examination. Does This Woman Have Osteoporosis?

• Arch Intern Med 13/27 dicembre
  • Unregulated Direct-to-Consumer Marketing and Self-referral for Screening Imaging Services

• BMJ, 11 dicembre
  • Trial protocols at the BMJ
  • Do biomedical models of illness make for good healthcare systems?

• JAMA, 8 dicembre
  • Accessibility and Accuracy of Web Page References in 5 Major Medical Journals
  • Digital Information Archiving Policies in High-Impact Medical and Scientific Periodicals

• CMAJ, 7 dicembre
  • Incidence of and risk factors for nodding off at scientific sessions
  • Excess in the pharmaceutical industry
  • How to read clinical journals: XII. How you too can profit from pharmaceutical advertisements
  • A view from the Internet age: Let's build a health system that meets the needs of the next generation

• Med J Aust, 6-20 dicembre
  • "Without research, there is no hope”
  • Leadership in medicine: where are the leaders?

• Nuovi libri dal Pensiero Scientifico Editore
  • Governo clinico
  • Linee guida per la pratica clinica
  • La gestione del rischio nelle organizzazioni sanitarie

• Bandolier, 127

• Lancet, 4 dicembre
  • Rosuvastatin and the statin wars--the way to peace

• BMJ, 4 dicembre
  • Dealing with editorial misconduct
  • Learning in practice. Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department

• N Engl J Med, 2 dicembre
  • Medical Research and the News Media

• JAMA 1 dicembre
  • Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs
  • Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
  • Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: A Counterpoint
  • Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
  • Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
  • Authors’ Reply to Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"

• BMJ, 27 novembre
  • The white paper on public health
  • Government programmes driven by politics not evidence, report says

• JAMA, 24 novembre
  • Shared Medical Decision Making: Problems, Process, Progress

• CMAJ, 23 novembre
  • Conflicts of interests and investments
  • Transparency in drug regulation: Mirage or oasis?
  • Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic)

• N Engl J Med, 18 novembre
  • Business and Medicine: Merck's Recall of Rofecoxib — A Strategic Perspective

• Ann Intern Med, 16 novembre
  • Measuring the Quality of Physician Practice by Using Clinical Vignettes: A Prospective Validation Study
  • Back to the Future: Clinical Vignettes and the Measurement of Physician Performance
  • Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement  
  • Inequality in Health Care: Unjust, Inhumane, and Unattended!

• Med J Aust, 15 novembre
  • Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions
  • Trials on trial. Generalising the results of trials to clinical practice

• BMJ, 13 novembre
  • Users' guide to detecting misleading claims in clinical research reports

• Lancet, 13 novembre
  • The whole truth and nothing but the truth? The research that Philip Morris did not want you to see
  • Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
  • Vioxx, the implosion of Merck, and aftershocks at the FDA
  • How, where, and when should trial data be reported?

• N Engl J Med, 11 novembre
  • Improving Patient Safety — Five Years after the IOM Report

• JAMA, 10 novembre
  • Health Care Information Technology: Progress and Barriers

• CMAJ, 9 novembre
  • Optimal search strategies for detecting health services research studies in MEDLINE
  • Global health indicators: an overview

• Lancet 6 novembre
  • Medical professionalism
  • Professionalism and the medical student
  • A lesson from the third year
  • Independent clinical research in Europe

• JAMA, 3 novembre
  • Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative
  • Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
  • Risks and Benefits of Phase 1 Clinical Trials Evaluating New Anticancer Agents: A Case for More Innovation

• Bandolier 126

• MJA, 1 novembre
  • Teaching on the run tips 6: determining competence

• Lancet, 30 ottobre
  • Use of research to inform public policymaking
  • Pushing the international health research agenda towards equity and effectiveness

• BMJ, 30 ottobre
  • Theme Issue. What's the evidence that evidence based medicine changes anything?

• N Engl J Med, 28 ottobre
  • Registration of Clinical Trials — Voluntary or Mandatory?
  • Doctors and Drug Companies
  • Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal Prosecution

• JAMA, 27 ottobre
  • The Rational Clinical Examination. Does This Patient Have an Instability of the Shoulder or a Labrum Lesion?

• CMAJ, 26 ottobre
  • Carrots and sticks for quality health care
  • Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial

• Lancet, 23 ottobre
  • Achieving universal coverage with health interventions

• BMJ, 23 ottobre
  • Placebos in practice
  • Individual response to treatment: is it a valid assumption?
  • The PROGRESS trial three years later: time for a balanced report of effectiveness
  • Commentary: The PROGRESS trial three years later: time for more action, less distraction
  • Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

• MJA, 18 ottobre
  • Research ethics committees: what is their contribution?
  • Trials on Trial. Multiple analyses in clinical trials: sound science or data dredging?

• BMJ, 16 ottobre
  • Lessons from the withdrawal of rofecoxib
  • The scandal of poor epidemiological research
  • WMA sets rules on how doctors handle industry sponsorship
  • Issues in the reporting of epidemiological studies: a survey of recent practice
  • Quality improvement report.Introduction of nurse led DC cardioversion service in day surgery unit: prospective audit

• Lancet, 16 ottobre
  • NIH research: widening access, building collaboration
  • How to bridge the gap in human resources for health
  • Prescribing sentence: time for evidence-based justice

• N Engl J Med, 14 ottobre
  • Failing the Public Health — Rofecoxib, Merck, and the FDA
  • Coxibs and Cardiovascular Disease
  • Controlling health care costs

• JAMA, 13 ottobre
  • Duplicate Publication, Multiple Problems

• CMAJ, 12 ottobre
  • Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets
  • Randomized clinical trials: Slow death by a thousand unnecessary policies?

• Arch Intern Med, 11 ottobre
  • Polypharmacy: A New Paradigm for Quality Drug Therapy in the Elderly?

• BMJ, 9 ottobre
  • Learning in practice. What can experience add to early medical education? Consensus survey

• Lancet, 9 ottobre
  • Vioxx: an unequal partnership between safety and efficacy
  • Health financing to promote access in low income settings--how much do we know?

• JAMA, 6 ottobre
  • Interventions to Improve Research Participants' Understanding in Informed Consent for Research: A Systematic Review
  • Accuracy of Diagnostic Tests Read With and Without Clinical Information: A Systematic Review

• BMJ, 2 ottobre: Theme issue: Academic Medicine
  • ICRAM (the International Campaign to Revitalise Academic Medicine): agenda setting
  • Academic medicine: the evidence base

• Lancet, 2 ottobre
  • Evidence-based action needed on health systems
  • Making health systems more equitable

• Bandolier 125

• CMAJ, 28 settembre
  • The Cochrane Collaboration at 10: kudos and challenges
  • Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
  • So what has the Cochrane Collaboration ever done for us? A report card on the first 10 years
  • Registering CIHR-funded randomized controlled trials: a global public good

• BMJ, 25 settembre
  • Taking account of future technology in cost effectiveness analysis

• Lancet, 25 settembre
  • Misinterpretation of numbers: a potential source of physician's error

• JAMA 22/29 settembre
  • The Rational Clinical Examination. Does This Patient Have a Family History of Cancer?: An Evidence-Based Analysis of the Accuracy of Family Cancer History

• MJA, 20 settembre
  • Teaching on the run tips 5: teaching a skill

• BMJ, 18 settembre
  • Compulsory registration of clinical trials
  • Quality improvement programme to achieve acceptable colonoscopy completion rates: prospective before and after study
  • Making clinical governance work
  • Commentary: Model could work

• N Engl J Med, 16 settembre
  • Becoming a Physician: Learner-Centered Medical Education

• JAMA, 15 settem,bre
  • Trial Registration: A Great Idea Switches From Ignored to Irresistible

• CMAJ, 14 settembre
  • Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals)

• Arch Intern Med, 13 settembre
  • Don't Ask, Don't Tell: The Status of Doctor-Patient Communication About Health Care Costs
  • Cost-Related Medication Underuse: Do Patients With Chronic Illnesses Tell Their Doctors?

• BMJ, 11 settembre
  • Learning in practice.Using computers for assessment in medicine

• Lancet, 11 settembre
  • Clinical trial registration: a statement from the International Committee of Medical Journal Editors
  • Informed choices for attaining the Millennium Development Goals: towards an international cooperative agenda for health-systems research
  • The state of primary-care research

• BMJ, 4 settembre
  • Stopping clinical trials early
  • Relation between online "hit counts" and subsequent citations: prospective study of research papers in the BMJ
  • Consent to the publication of patient information

• N Engl J Med, 2 settembre
  • Conflicts of Interest at the NIH — Resolving the Problem

• JAMA, 1 settembre
  • Educational Epidemiology: Applying Population-Based Design and Analytic Approaches to Study Medical Education

• Bandolier, 124

• CMAJ, 31 agosto
  • Variations in rates of appropriate and inappropriate carotid endarterectomy for stroke prevention in 4 Canadian provinces
  • The inappropriate use of carotid endarterectomy
  • Editors' declaration of their own conflicts of interest

• BMJ, 28 agosto
  • Screening research papers by reading abstracts
  • Quality improvement report.Using rapid-cycle quality improvement methodology to reduce feeding tubes in patients with advanced dementia: before and after study
  • Use of decision aids to support informed choices about screening
  • Experiences of the BMJ ethics committee

• Lancet, 28 agosto
  • Clinical trials in children
  • Improving surgical consent

• N Engl J Med, 26 agosto
  • The Pharmaceutical Industry — Prices and Progress

• JAMA, 18 agosto
  • Surgical Mortality as an Indicator of Hospital Quality: The Problem With Small Sample Size

• CMAJ, 17 agosto
  • Tips for learning and teaching evidence-based medicine: introduction to the series
  • Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat
  • Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond

• MJA, 16 agosto
  • Trials on Trial. Balancing the outcomes: reporting adverse events

• N Engl J Med, 12 agosto
  • Sins of Omission — Cancer Research without Informed Consent
  • Becoming a Physician: The Road Less Traveled — Attracting Students to Primary Care
  • The Future of Primary Care Medicine

• Arch Intern Med, 9-23 agosto
  • The Overlecturing and Underteaching of Clinical Medicine
  • Inappropriate Prescribing for Elderly Americans in a Large Outpatient Population
  • Communicating With Patients About Medical Errors: A Review of the Literature

• BMJ, 7 agosto

  • Learning in practice

    • New perspectives—approaches to medical education at four new UK medical schools

    • Commentary: Promises and delivery—a research imperative for new approaches to medical education

    • The ethics of medical education

    • Commentary: Patients in medical education and research

• MJA, 2 agosto

  • Teaching on the run tips 4: teaching with patients

• Lancet, 31 luglio

  • Beyond the evidence in clinical guidelines

  • An experimental study of determinants of group judgments in clinical guideline development 

• BMJ, 31 luglio

  • Clinical research under the cosh again

  • Evidence based case report: Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome

  • Academic medicine campaign: Obstacles to conducting epidemiological research in the UK general population

  • The other face of research governance

  • Commentary: View from the research and development office

  • Bureaucracy of ethics applications

  • Commentary: Better support for investigators is essential

  • Research ethics paperwork: what is the plot we seem to have lost?

  • Ethical review of research into rare genetic disorders

• N Engl J Med, 29 luglio

  • Beyond Fast Track for Drug Approvals

• Bandolier, 123

• BMJ, 24 luglio

  • The triumph of NICE

  • Which drugs should be available over the counter?

  • Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution

  • National Institute for Clinical Excellence and its value judgments

  • Challenges for the National Institute for Clinical Excellence

• N Engl J Med, 22 luglio

  • Public Registration of Clinical Trials

• CMAJ, 20 luglio

  • CME and the pharmaceutical industry: two worlds, three views, four steps

  • The future sponsorship of CME in Canada: Industry, government, physicians or a blend?

•  

• Lancet, 17 luglio

  • Health information for all by 2015?

  • Can we achieve health information for all by 2015

• BMJ, 17 luglio

  • Diagnostic tests 4: likelihood ratios

• Bandolier 122

• BMJ, 10 luglio

  • Open access to industry's clinically relevant data

  • Comparison of reporting of ethnicity in US and European randomised controlled trials

  • Learning in practice. Reform of undergraduate medical teaching in the United Kingdom: a triumph of evangelism over common sense

• JAMA, 7 luglio

  • Authorship Criteria and Disclosure of Contributions: Comparison of 3 General Medical Journals With Different Author Contribution Forms

• Ann Intern Med, 6 luglio

  • Publishing Commentary by Authors with Potential Conflicts of Interest: When, Why, and How

• MJA, 5 luglio

  • What conflict of interest?

• BMJ, 3 luglio. Theme Issue

  • Balancing benefit and harms in health care 

• BMJ, 26 giugno

  • Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis

  • Learning in practice

    • "Not a university type": focus group study of social class, ethnic, and sex differences in school pupils' perceptions about medical school

    • The standardised admission ratio for measuring widening participation in medical schools: analysis of UK medical school admissions by ethnicity, socioeconomic status, and sex

    • Complex interventions: how "out of control" can a randomised controlled trial be?

• CMAJ, 22 giugno

  • Author self-citation in the diabetes literature

  • Author self-citation in medical literature

• MJA, 21 giugno

  • Evidence and Australian health policy

  • The Australian Government’s Review of Positron Emission Tomography: evidence-based policy-making in action

  • The Australian Government’s Review of Positron Emission Tomography: an open door

  • Teaching on the run tips 3: planning a teaching episode

• Bobbio M. Giuro di esercitare la medicina in libertà e indipendenza. Einaudi 2004

• BMJ, 19 giugno

  • Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis

  • Cross sectional survey of multicentre clinical databases in the United Kingdom

  • Grading quality of evidence and strength of recommendations

  • Medical researchers' ancillary clinical care responsibilities

• BMJ, 12 giugno

  • Choice and equity: lessons from long term care

  • Hands-on guide to questionnaire research: Reaching beyond the white middle classes

• Lancet, 12 giugno

  • Is GSK guilty of fraud?

• JAMA, 9 giugno

  • The Rational Clinical Examination. Is This Child Dehydrated?

• CMAJ, 8 giugno

  • From bench to bedside and back again?

  • The high costs of for-profit care

  • Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis

• MJA, 7 giugno

  • My pseudoscientific nightmare

• BMJ, 5 giugno

  • Financial incentives for doctors

  • Authors' perceptions of electronic publishing: two cross sectional surveys

  • Hands-on guide to questionnaire research. Administering, analysing, and reporting your questionnaire

• N Engl J Med, 3 giugno

  • A Middle Ground on Public Accountability

• JAMA, 2 giugno

  • Evidence-Based Global Health

• Ann Intern Med, 1 giugno

  • Effects of Training in Direct Observation of Medical Residents' Clinical Competence: A Randomized Trial

  • Creating the Evidence Base for Quality Improvement Collaboratives

  • A New Model for Accreditation of Residency Programs in Internal Medicine

  • Observational Studies of Treatment Effectiveness: Some Cautions

  • Quality of Care and Quality of Training: A Shared Vision for Internal Medicine?

• Bandolier 121

• BMJ, 29 maggio

  • Hands-on guide to questionnaire research: Selecting, designing, and developing your questionnaire

• CMAJ, 25 maggio

  • Relation between randomized controlled trials published in leading general medical journals and the global burden of disease

  • The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada

  • Evidence for global health

  • Health care as a risk factor

• BMJ, 22 maggio

  • Another threat to research in the United Kingdom

  • Representation of authors and editors from countries with different human development indexes in the leading literature on tropical medicine: survey of current evidence

  • Review of instruments for peer assessment of physicians

  • "Soft" assessment—an oxymoron?

  • What the educators are saying

• Lancet, 22 maggio

  • OTC statins: a bad decision for public health

  • Beyond randomised versus observational studies

  • Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

  • When are observational studies as credible as randomised trials?

• N Engl J Med, 20 maggio

  • Medicare Coverage for Technological Innovations — Time for New Criteria?

• Ann Intern Med, 18 maggio

  • Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting

• MJA, 17 maggio

  • Teaching on the run tips 2: educational guides for teaching in a clinical setting

• BMJ, 15 maggio.

  • Theme Issue. How electronic communication is changing health care

• Lancet, 15 maggio

  • European Clinical Trials Directive: the Italian position

• N Engl J Med, 13 maggio

  • "I Swear by Apollo" — On Taking the Hippocratic Oath

• Lancet, 8 maggio

  • Assessment of NICE guidance on two surgical procedures

  • Educating, with evidence

• Ann Intern Med, 4 maggio

  • The Quality of Pharmacologic Care for Vulnerable Older Patients

  • Patient Education Materials about the Treatment of Early-Stage Prostate Cancer: A Critical Review

• BMJ, 1 maggio

  • Data protection, informed consent, and research

  • Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey

  • Statistics Notes: The logrank test

• Lancet, 1 maggio

  • Registering clinical trials: an essential role for WHO

• CMAJ, 27 aprile

  • Medical research, the media and open access

  • Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers

  • Science reporting to the public: Does the message get twisted?

  • Considerations and costs of disclosing study findings to research participants

• Bandolier 120

• BMJ, 24 aprile

  • Making public health interventions more evidence based

  • Payment by results—new financial flows in the NHS

  • New Cochrane policy tightens limits on industry funding

  • Learning in practice. The need for needs assessment in continuing medical education

  • Integrating qualitative research with trials in systematic reviews

  • Assessing ethics of trials in systematic reviews

• Lancet, 24 aprile

  • Depressing research

  • Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

• JAMA, 21 aprile

  • Economic Implications of Evidence-Based Prescribing for Hypertension: Can Better Care Cost Less?

  • Reinvention of Health Insurance in the Consumer Era

• Ann Intern Med, 20 aprile

  • Health Care System Chaos Should Spur Innovation: Summary of a Report of the Society of General Internal Medicine Task Force on the Domain of General Internal Medicine

• MJA, 19 aprile

  • The beginning of the end for EBM

  • The campaign to revitalise academic medicine kicks off

  • Tested teaching tips

  • The medical profession and the pharmaceutical industry: when will we open our eyes?

  • The ethics of pharmaceutical industry relationships with medical students

  • Teaching on the run 1.Teaching on the run tips: doctors as teachers

• BMJ, 17 aprile

  • Evidence based policy or policy based evidence?

  • Hospitals' star ratings and clinical outcomes: ecological study

  • Quality improvement report. Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study

  • Clinical reasoning

  • Development of clinical ethics committees

• Lancet 17 aprile

  • Inpatient safety 5. Improving care of the critically ill: institutional and health-care system approaches

• Lancet 10 aprile

  • Inpatient safety 4. Improving patients' safety locally: changing clinician behaviour

• Lancet, 3 aprile

  • Inpatient safety 3. se and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma

• Workshop report "Decisioni Cliniche e Prove di Efficacia". 2a edizione

• Lancet, 27 marzo

  • Inpatient safety 2. How can clinicians measure safety and quality in acute care?

• BMJ, 27 marzo

  • Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial

  • Evidence based case report: Perimacular retinal folds from childhood head trauma

• BMJ, 20 marzo

  • Extending CONSORT to include cluster trials

  • Improving peer review: who's responsible?

  • BMJ training for peer reviewers

  • Effects of training on quality of peer review: randomised controlled trial

  • CONSORT statement: extension to cluster randomised trials

• Lancet, 20 marzo

  • Inpatient safety 1. Challenges in the care of the acutely ill

  • Why blame systems for unsafe care?

• JAMA, 17 marzo

  • The Rational Clinical Examination. Evaluation of Vaginal Complaints

• Ann Intern Med, 16 marzo

  • Addressing the Limitations of Structured Abstracts

• MJA, 16 marzo

  • Subgroup analysis in clinical trials

• MJA, 15 marzo

  • Supplement: Adopting Best Evidence in Practice.

• N Engl J Med, 11 marzo

  • Data Safety and Monitoring Boards

• BMJ, 6 marzo

  • What's the E for EBM?

  • Efficiency, equity, and NICE clinical guidelines

• Lancet, 6 marzo

  • Retraction of an interpretation

• MJA, 1 marzo

  • The science of changing providers’ behaviour: the missing link in evidence-based practice

• Bandolier, dicembre 2003

• BMJ, 28 febbraio

  • What doesn't work and how to show it

  • Why do doctors use treatments that do not work?

  • Well informed uncertainties about the effects of treatments

  • Absence of evidence is not evidence of absence

  • Where is the evidence that animal research benefits humans?

  • Synthesising licensing data to assess drug safety

• JAMA, 25 febbraio

  • Different Patterns of Duplicate Publication: An Analysis of Articles Used in Systematic Reviews

• N Engl J Med, 26 febbraio

  • Britain's National Health Service Revisited

• Lancet, 21 febbraio

  • A statement by the Editors of The Lancet

• JAMA, 18 febbraio

  • NIH Peer Review of Grant Applications for Clinical Research

  • The Rational Clinical Examination. Is This Patient Dead, Vegetative, or Severely Neurologically Impaired?: Assessing Outcome for Comatose Survivors of Cardiac Arrest

  • The Clinical Researcher—An "Emerging" Species

• CMAJ, 17 febbraio

  • The "file drawer" phenomenon: suppressing clinical evidence

  • Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials

  • Randomized clinical trials: What gets published, and when?

• Ann Intern Med, 17 febbraio

  • Medical Device Regulation: An Introduction for the Practicing Physician

• MJA, 16 febbraio

  • Managing allegations of scientific misconduct and fraud: lessons from the “Hall affair”

• BMJ, 14 febbraio

  • Cochrane proposes further limits on commercial funding

  • Paying for statins

  • Patient commentary: paying to choose

• BMJ, 7 febbraio

  • Screening without evidence of efficacy

  • Changing clinical behaviour by making guidelines specific

• N Engl J Med, 5 febbraio

  • The Pharmaceutical Industry versus Medicaid — Limits on State Initiatives to Control Prescription-Drug Costs

• JAMA, 5 febbraio

  • Ethical Issues Concerning Research in Complementary and Alternative Medicine

• CMAJ, 3 febbraio

  • Academic medicine: resuscitation in progress

  • Do pharmacists' presence on rounding teams reduce preventable adverse drug events in hospital general medical units?

• Ann Intern Med, 3 febbraio

  • Sources of Variation and Bias in Studies of Diagnostic Accuracy: A Systematic Review

  • "Special Scrutiny": A Targeted Form of Research Protocol Review

  • The Media Matter: A Call for Straightforward Medical Reporting

• Am Fam Phys, 1 febbraio

  • Strength of Recommendation Taxonomy (SORT): A Patient-Centered Approach to Grading Evidence in the Medical Literature

 

19 gennaio - 1 febbraio

• BMJ, 31 gennaio

  • Quality improvement report: Clinical risk management in obstetrics: eclampsia drills

  • Evaluating the health effects of social interventions

• Arch Intern Med, 26 gennaio

  • Get With the Guidelines for Cardiovascular Secondary Prevention: Pilot Results

• Lancet, 24 gennaio

  • Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

  • Communicating sad, bad, and difficult news in medicine

• BMJ, 24 gennaio

  • Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals

  • Learning in practice. Cohort study of examination performance of undergraduate medical students learning in community settings

  • Rethinking management of chronic diseases

  • Can the NHS learn from US managed care organisations?

• N Engl J Med, 22 gennaio

  • Financial Conflicts of Interest and the NIH

  • Paying Physicians for High-Quality Care

• JAMA, 21 gennaio

  • Surveillance of Medical Device–Related Hazards and Adverse Events in Hospitalized Patients

• CMAJ, 20 gennaio

  • Does universal comprehensive insurance encourage unnecessary use? Evidence from Manitoba says "no"

• Bandolier, 117

• BMJ, 17 gennaio

  • Ethics review roulette: what can we learn?

  • Comparison of requirements of research ethics committees in 11 European countries for a non-invasive interventional study

  • Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study

  • Not everything that counts can be counted; not everything that can be counted counts

  • Public involvement in health care

  • Using industrial processes to improve patient care

• Lancet, 17 gennaio

  • Research and development costs for drugs

• N Engl J Med, 15 gennaio

  • "Me-Too" Products — Friend or Foe?

• JAMA, 14 gennaio

  • Improving Cardiac Surgery Quality—Volume, Outcome, Process?

• BMJ, 10 gennaio

  • Preserving today's scientific record for tomorrow

  • Scottish doctors will have to register financial links to drug companies

• N Engl J Med, 8 gennaio

  • Peer Review and Federal Regulations

  • Inserting Government between Patient and Physician

• JAMA, 7 gennaio

  • National Use of Postmenopausal Hormone Therapy: Annual Trends and Response to Recent Evidence

  • Impact of Clinical Trial Results on National Trends in -Blocker Prescribing, 1996-2002

  • The Complex World of Prescribing Behavior

• CMAJ, 6 gennaio

  • Medical journals and global medicine

• BMJ, 3 gennaio

  • Open access publishing takes off

  • Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group

  • Commentary: The quality of randomised controlled trials may be better than assumed

  • Assessing the quality of research

• Lancet, 3 gennaio

  • The Lancet's policy on conflicts of interest--2004

• Lancet 1 gennaio
  • Evidence-based practice and the individual
  • Treating Individuals 1 :External validity of randomised controlled trials: "To whom do the results of this trial apply?"

• BMJ 1 gennaio
  • The GMC: expediency before principle
  • Direct to consumer advertising
  • ABC of preterm birth: Evidence based care
  • Switching prescription drugs to over the counter

• N Engl J Med, 30 dicembre
  • Potential Pitfalls of Disease-Specific Guidelines for Patients with Multiple Conditions

• BMJ, 18 dicembre
  • Lifting the fog of uncertainty from the practice of medicine
  • The Decameron of poor research
  • A field guide to experts
  • Easy ways to resist change in medicine
  • Killing me softly: myth in pharmaceutical advertising

• JAMA, 15 dicembre
  • The Rational Clinical Examination. Does This Woman Have Osteoporosis?

• Arch Intern Med 13/27 dicembre
  • Unregulated Direct-to-Consumer Marketing and Self-referral for Screening Imaging Services

• BMJ, 11 dicembre
  • Trial protocols at the BMJ
  • Do biomedical models of illness make for good healthcare systems?

• JAMA, 8 dicembre
  • Accessibility and Accuracy of Web Page References in 5 Major Medical Journals
  • Digital Information Archiving Policies in High-Impact Medical and Scientific Periodicals

• CMAJ, 7 dicembre
  • Incidence of and risk factors for nodding off at scientific sessions
  • Excess in the pharmaceutical industry
  • How to read clinical journals: XII. How you too can profit from pharmaceutical advertisements
  • A view from the Internet age: Let's build a health system that meets the needs of the next generation

• Med J Aust, 6-20 dicembre
  • "Without research, there is no hope”
  • Leadership in medicine: where are the leaders?

• Nuovi libri dal Pensiero Scientifico Editore
  • Governo clinico
  • Linee guida per la pratica clinica
  • La gestione del rischio nelle organizzazioni sanitarie

• Bandolier, 127

• Lancet, 4 dicembre
  • Rosuvastatin and the statin wars--the way to peace

• BMJ, 4 dicembre
  • Dealing with editorial misconduct
  • Learning in practice. Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department

• N Engl J Med, 2 dicembre
  • Medical Research and the News Media

• JAMA 1 dicembre
  • Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs
  • Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
  • Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: A Counterpoint
  • Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
  • Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
  • Authors’ Reply to Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"

• BMJ, 27 novembre
  • The white paper on public health
  • Government programmes driven by politics not evidence, report says

• JAMA, 24 novembre
  • Shared Medical Decision Making: Problems, Process, Progress

• CMAJ, 23 novembre
  • Conflicts of interests and investments
  • Transparency in drug regulation: Mirage or oasis?
  • Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic)

• N Engl J Med, 18 novembre
  • Business and Medicine: Merck's Recall of Rofecoxib — A Strategic Perspective

• Ann Intern Med, 16 novembre
  • Measuring the Quality of Physician Practice by Using Clinical Vignettes: A Prospective Validation Study
  • Back to the Future: Clinical Vignettes and the Measurement of Physician Performance
  • Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement  
  • Inequality in Health Care: Unjust, Inhumane, and Unattended!

• Med J Aust, 15 novembre
  • Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions
  • Trials on trial. Generalising the results of trials to clinical practice

• BMJ, 13 novembre
  • Users' guide to detecting misleading claims in clinical research reports

• Lancet, 13 novembre
  • The whole truth and nothing but the truth? The research that Philip Morris did not want you to see